Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2023-04-04 Report Publication Anno…
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
[기재정정]기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a regulatory filing (a 'Correction Report') announcing the scheduling and details of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting. Since this is an announcement of an event rather than the presentation materials themselves, and it is a formal regulatory filing regarding the scheduling of an IR event, it falls under the RNS (Regulatory Filings) category as a general regulatory announcement.
2023-04-04 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It is addressed to the Financial Services Commission/Korea Exchange and details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation does not fit into the specific categories of 'Share Issue/Capital Change' (which usually refers to new share issuance or stock splits) or 'Director's Dealing' (which refers to personal trades). As it is a specific regulatory disclosure regarding stock options, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for miscellaneous corporate regulatory announcements.
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회 결과) for the company SR Biotech. It details the approval of financial statements, director and auditor appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the outcome of shareholder votes at the AGM.
2023-03-31 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2022, covering the period from January 1, 2022, to December 31, 2022. It contains detailed company information, management discussion, financial history, and business operations. In the context of Korean corporate filings, this is the standard annual comprehensive report submitted to the Financial Supervisory Service (FSS), which corresponds to the 10-K filing type in the provided schema. FY 2022
2023-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing (under 5,000 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion and key financial figures, serving as an official notification that the audit report has been submitted to the regulatory body. According to the 'Menu vs Meal' rule, this is an announcement of the report rather than the full audit report itself, making it a Report Publication Announcement (RPA). FY 2022
2023-03-21 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SR Biotech. It contains the meeting agenda, including the approval of financial statements, election of directors, and remuneration limits. While it contains financial data, it is explicitly a notice for an upcoming meeting rather than the final Annual Report or a standalone financial report. According to the provided definitions, documents detailing the agenda and materials for an AGM are classified as AGM-R.
2023-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.